These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29757039)

  • 21. Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists.
    Guariento S; Tonelli M; Espinoza S; Gerasimov AS; Gainetdinov RR; Cichero E
    Eur J Med Chem; 2018 Feb; 146():171-184. PubMed ID: 29407948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial - Membrane protein tools for drug discovery.
    Jawhari A
    Methods; 2020 Aug; 180():1-2. PubMed ID: 32736003
    [No Abstract]   [Full Text] [Related]  

  • 23. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.
    Espinoza S; Lignani G; Caffino L; Maggi S; Sukhanov I; Leo D; Mus L; Emanuele M; Ronzitti G; Harmeier A; Medrihan L; Sotnikova TD; Chieregatti E; Hoener MC; Benfenati F; Tucci V; Fumagalli F; Gainetdinov RR
    Neuropsychopharmacology; 2015 Aug; 40(9):2217-27. PubMed ID: 25749299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The discovery of potent agonists for GPR88, an orphan GPCR, for the potential treatment of CNS disorders.
    Bi Y; Dzierba CD; Fink C; Garcia Y; Green M; Han J; Kwon S; Kumi G; Liang Z; Liu Y; Qiao Y; Zhang Y; Zipp G; Burford N; Ferrante M; Bertekap R; Lewis M; Cacace A; Westphal RS; Kimball D; Bronson JJ; Macor JE
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1443-7. PubMed ID: 25754495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods to measure g-protein-coupled receptor activity for the identification of inverse agonists.
    Barreda-Gómez G; Teresa Giralt M; Rodríguez-Puertas R
    Methods Enzymol; 2010; 485():261-73. PubMed ID: 21050922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent advances in drug discovery of GPCR allosteric modulators for neurodegenerative disorders.
    Lütjens R; Rocher JP
    Curr Opin Pharmacol; 2017 Feb; 32():91-95. PubMed ID: 28135635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches for Differentiation and Interconverting GPCR Agonists and Antagonists.
    Miszta P; Jakowiecki J; Rutkowska E; Turant M; Latek D; Filipek S
    Methods Mol Biol; 2018; 1705():265-296. PubMed ID: 29188567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
    Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
    Pei Y; Mortas P; Hoener MC; Canales JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():70-5. PubMed ID: 26048337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analyzing biased responses of GPCR ligands.
    Benredjem B; Dallaire P; Pineyro G
    Curr Opin Pharmacol; 2017 Feb; 32():71-76. PubMed ID: 27930943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FFA4/GPR120 agonists: a survey of the recent patent literature.
    Formicola R; Pevarello P; Kuhn C; Liberati C; Piscitelli F; Sodano M
    Pharm Pat Anal; 2015; 4(6):443-51. PubMed ID: 26580993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1.
    Wainscott DB; Little SP; Yin T; Tu Y; Rocco VP; He JX; Nelson DL
    J Pharmacol Exp Ther; 2007 Jan; 320(1):475-85. PubMed ID: 17038507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New concepts in drug discovery: collateral efficacy and permissive antagonism.
    Kenakin T
    Nat Rev Drug Discov; 2005 Nov; 4(11):919-27. PubMed ID: 16264435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GPCR Drug Discovery: Emerging Targets, Novel Approaches and Future Trends.
    Zhou J; Wild C
    Curr Top Med Chem; 2019; 19(16):1363-1364. PubMed ID: 31513505
    [No Abstract]   [Full Text] [Related]  

  • 35. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics.
    Black SW; Schwartz MD; Chen TM; Hoener MC; Kilduff TS
    Biol Psychiatry; 2017 Nov; 82(9):623-633. PubMed ID: 27919403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent updates on GPCR biased agonism.
    Pupo AS; Duarte DA; Lima V; Teixeira LB; Parreiras-E-Silva LT; Costa-Neto CM
    Pharmacol Res; 2016 Oct; 112():49-57. PubMed ID: 26836887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAAR1-dependent effects of apomorphine in mice.
    Sukhanov I; Espinoza S; Yakovlev DS; Hoener MC; Sotnikova TD; Gainetdinov RR
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1683-93. PubMed ID: 24925023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective GPCR ligands.
    Gmeiner P
    Bioorg Med Chem; 2015 Jul; 23(14):3879. PubMed ID: 25818769
    [No Abstract]   [Full Text] [Related]  

  • 40. Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.
    Hu LA; Zhou T; Ahn J; Wang S; Zhou J; Hu Y; Liu Q
    Biochem J; 2009 Oct; 424(1):39-45. PubMed ID: 19725810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.